FTC Chair Signals Possible Lawsuits Against Drug Companies, Continues Orange Book Probe

By Maaisha Osman / September 26, 2024 at 5:10 PM

FTC Chair Lina Khan confirmed that the commission is exploring possible lawsuits against drug manufacturers and will continue working to stop “junk” patent listings in FDA’s Orange Book, despite a former commissioner questioning FTC’s expertise in patent law.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.